Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Current Deferred Revenue (2016 - 2017)

Innospec (IOSP) has disclosed Current Deferred Revenue for 8 consecutive years, with $100000.0 as the latest value for Q4 2017.

  • Quarterly Current Deferred Revenue changed 0.0% to $100000.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2017, changed 0.0% year-over-year, with the annual reading at $100000.0 for FY2017, 0.0% changed from the prior year.
  • Current Deferred Revenue hit $100000.0 in Q4 2017 for Innospec, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $300000.0 in Q4 2013 to a low of $100000.0 in Q1 2013.
  • Historically, Current Deferred Revenue has averaged $175000.0 across 5 years, with a median of $200000.0 in 2014.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 95.45% in 2013 and later skyrocketed 200.0% in 2014.
  • Year by year, Current Deferred Revenue stood at $300000.0 in 2013, then crashed by 33.33% to $200000.0 in 2014, then changed by 0.0% to $200000.0 in 2015, then plummeted by 50.0% to $100000.0 in 2016, then changed by 0.0% to $100000.0 in 2017.
  • Business Quant data shows Current Deferred Revenue for IOSP at $100000.0 in Q4 2017, $100000.0 in Q3 2017, and $100000.0 in Q2 2017.